Touring grossed $2.7 billion. The rooms you book lost nearly 9%.

The 2026 midyear touring numbers landed this month, and the trade headline writes itself: the top 50 tours grossed $2.7 billion, up 8.4% year over year. The rooms you actually book — 2,500-cap and under — lost nearly 9% of their gross over the same six months.

Both numbers come from the same report: Billboard Pro’s 2026 Midyear Boxscore, covering October 1, 2025 through March 31, 2026. They describe the same live-music economy. They just describe different ends of it.

The “touring is booming” story is true. It is also not yours. The boom is stacked at the top of the capacity ladder, and the bottom — the tier independent promoters live in — is moving the other way — the same squeeze is hollowing out the mid-tier festival. This is a K-shaped market, and the headline only reports the upper arm.

The money is moving up the capacity ladder, not across it

Read the report by venue tier and the divergence is clean. Stadiums, arenas, and amphitheaters are up more than 20% across the board. The 5,001-to-10,000-cap tier is up 7.3%. Then the floor drops: rooms of 2,500-cap and under fell almost 9% in gross and 6% in attendance.

That is not the same demand spread evenly. It is spend climbing the ladder and thinning at the bottom rung.

One number cuts against the boom even at the top, and it is worth stating plainly: that $2.7 billion is still 16% below 2024’s $3.2 billion. Read that as normalization, not a crash. 2024 was inflated by the Taylor Swift and Beyoncé supercycle — a once-a-decade pull that was never the baseline. The top is settling back toward trend while still growing year over year. The bottom is the part genuinely contracting. The story is the divergence, not a top-line collapse.

A falling average ticket is the part you can’t price around

The bottom tier didn’t just sell for less. It sold to fewer people. Gross down almost 9% with attendance down 6% means this is demand softening, not only price — you can’t explain a 6% attendance drop with discounting.

The price line is bending at the top of the market. The top-tour average ticket came in at $130.36, down 6.3% from $139.09 a year ago. Two straight years of decline now, after a 5.5% drop the year before. The top of the market is thinning too: five tours cleared $100 million this cycle, down from six in 2025 and eight in 2024.

This is the same floor we wrote about in the taxonomy of booking risk — the headline revenue is real and it is stacked at the stadium tier, while the club two miles away sells fewer tickets every year. The midyear data just put a tier-level number on it.

The data shows the contraction. It does not prove the cause.

It is tempting to explain the soft bottom in one clean sentence. Resist it. The Boxscore shows what shrank; it does not show why, and we won’t pretend otherwise.

The plausible reads, flagged as hypotheses: a consumer discretionary squeeze that hits a $40 club ticket before a $300 stadium seat; fewer mid-level tours routing through small rooms, so the inventory at the bottom thins; headliner gravity pulling a fixed pool of live-music spend up-market. Any of these could be doing the work. The data is thin on which, and a confident guess here is worth less than the honest “we don’t know yet.”

What the data does support is narrower and more useful: if you book sub-2,500, the macro narrative is describing someone else’s year, and you should plan against the tier you’re actually in.

Three things to recheck on a sub-2,500 routing call

The boom headline is not an input to your next decision. These are.

Trust the comparable, not the headline tour. The $2.7 billion number tells you nothing about your room. A Comparable Show — a similar-sized artist, in a similar-sized room, recently — is the only data that maps to the bet in front of you. In a soft-bottom market the gap between “touring is up” and “this act sold 61% here last spring” is the entire decision.

Widen the downside in your revenue range. When attendance across the tier is down 6%, the soft case is more likely than it was a year ago, and your range should show it. Model the night where the walk-up doesn’t come. If the deal only works in the optimistic half of the range, it isn’t a book — it’s a wager. The mechanics of that math are in how to evaluate a booking offer.

Treat the falling average ticket as a reason to hold price discipline, not chase it. A softening tier is exactly when a guarantee gets bid up to win the date and the Sell-Through never arrives to cover it. Two years of declining average ticket says the room to raise price is shrinking. Price to what the comparable actually cleared, and let a date you have to overpay for walk.

The one for Monday

The boom is real. It is not yours, and booking as if it were is how a soft tier turns a thin guarantee into a loss you carry alone.

So before you answer the next offer in a sub-2,500 room: pull the last Comparable Show, price the guarantee to that gate, and widen the downside before you sign. That sourced price band — anchored to a real comparable, not the headline — is the discipline the $2.7 billion number can’t give you. The macro story belongs to the stadiums. Your P&L belongs to the room.